Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
again you appear painfully ignorant on the effects of the Medical business in regards to COVID. No one like s to use it it as an excuse not even Endra but it is a fact.
Probably the main reason the XBI is one of the worst performing sectors in the market.
No medical device company is using that reason anymore.. This was a simple, non complicated review.
Plus, they have had the equivalent approval in the EU for over two years and they have booked zero in revenue. Francois should be fired by the BOD..
Sorry it does COVID has delayed anything Medical and not Covid related 2 years. If you can't see that than you are blind.
Sorry dndodd, Covid had and has nothing to do with their predicament….
Definitely a casualty of COVID but they have to mange out of it. Time will tell if they can.
They had 8 million shares outstanding when I stumbled into them a few years ago, now they will have 60 million shares at $.26
Issue 20.6 million new shares? Is that correct? 40 million existing before offering
Endra Life Sciences (NASDAQ:NDRA) raised $8.7M year-to-date from the sale of common stock through its at the market, or ATM, equity facility.
Pursuant to its ATM equity offering sales agreement with Ascendiant Capital Markets, the company sold ~20.6M shares at an average price of $0.42/share.
If you like high risk situations like Titan why not?
Scooooooooooooooop??
New beginnings for sure. Looking forward to the stated promos and updates. Hold ‘em to it. GL
several significant potential catalysts in that response which are all in the latest Investor presentation available on their website.
Thank you for your email and interest in ENDRA Life Sciences.
As you know, the company does not control the stock’s trading activity, and the best way to address the stock’s performance is for the business to perform. Management is committed to executing its business strategy to commercialize the TAEUS system and looks forward to updating shareholders on material developments as appropriate.
As management stated in the last earnings conference call, there are several key milestones the company is striving to achieve this year including:
Advancing TAEUS through the US regulatory process and submitting a De Novo request,
Demonstrating TAEUS' clinical value by generating additional data with its evaluation sites to support its regulatory submission and commercialization,
Accelerating its commercial channel and marketing activities in line with the reopening of global markets to generate orders for TAEUS in Europe,
Securing additional pharmaceutical and other industry partnerships to expand the opportunity for TAEUS outside the clinical end-user market and
Continuing to strengthen its intellectual property portfolio to protect its proprietary technology, expand its potential area of use and increase out licensing opportunities.
Kind regards,
Yvonne
Don’t forget your fav went from this level to over $3 very quickly.
The difference Endra has a European approved product and are expecting sales anyway.
There is no cash, lost in space..
,,,,,,,HE’S GOT A BETTER SHOT@DOUBLING HIS..$$$$$
AT .23 THAN $2.42
Actually no I am not. Perfectly fine. No Debt No worries.
You must be very depressed?
I feel badly for you pal.
That is your opinion nothing more.
Nothing similar to this one it’s the worst of the worst.
Yep. lots of similar stories in the market not much Bullish is working well in this environment except maybe Energy, drilling, and utilities. Real estate too but with banks and the DJT going down things aren't looking very positive for the near future. Time will tell.
I feel for you, just terrible pal.
Of course the story is still the same. Only the price in a crazy market has changed.
Are you still long?
,,,,,,,Relax cash Position =buyout at this price not including company technology and all intellectual property assets
We’re golden
Email the BOD and demand Francois be fired. He has mislead this company for FOUR YEARS!
This f-ing stock just keeps falling
18th LAST SUBMISSION DAY….INTERNATIONAL LIVER CONFERENCE
Yes followed by new all time new highs in the next 12-24 months.
Why because of COVID delays.
Shouldn’t Francois step down as the CEO??
Of course it is James.
Company is legit. ?????
The only place that it will render MRI obsolete is in the measurement of Liver fat. Should do the same to taking a Liver Biopsy with a very long and large needle and all the potential complications that go with it.
ENDRA's TAEUS has the potential to render MRI technology obsolete. ENDRA's competent CEO Francois Michelon (https://www.linkedin.com/in/michelon) has deftly positioned his company with game-changing technology admirably protected by over 100 global patents. !/50th the cost of MRIs. Do your own DD! Company is legit.
$NDRA
,,,,,,,THE GOOD NEWS. Was told Buy-out likely in 90days
Some big wigs that are long here are very unhappy with our French Friend. Not an offer to buy or sell always do your dd
Weeeeeeeee!
ALERT ENDRA NEXT EVENT PARTICIPATES…INTERNATIONAL-LIVER-CONFERENCE
LOAD UP
https://endrainc.com/events
MARKETS CLOSED —FRIDAY. SO
add here or get off the train tomorrow
Some of you flip monkeys slowing us down
It’s trading like it’s got 1B…fricken shares.
Not 44M os
The market is acting like this is going out of business it will be proven wrong. IMHO
[FLOOD THEM WITH CALLS: 734-335-0468
ATTN: FRANCOIS
,,,,,,?Then we’d see $2 if that was the case
Francois must have been fired by the BOD. Just haven’t seen the filing yet. DNDODD?
Followers
|
51
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1231
|
Created
|
10/24/18
|
Type
|
Free
|
Moderators |
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |